BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) is divided into subtypes and circulating recombinant forms (CRFs) but the impact of subtype/CRF on disease progression is not fully understood. METHODS: We determined the HIV-1 subtype/CRF of 152 seroincident individuals from Guinea-Bissau, based on the C2-V3 region of env. Disease progression was measured as time from estimated seroconversion to AIDS and AIDS-related death. Hazard ratios (HRs) were calculated using a Cox proportional hazard model, adjusting for gender and age at seroconversion. RESULTS: The major subtypes/CRFs identified were CRF02_AG (53%), A3 (29%), and A3/02 (a recombinant of A3 and CRF02_AG) (13%). Infection with A3/02 was associated with a close to 3-fold increased risk of AIDS and AIDS-related death compared to A3 (HR = 2.6 [P = 0.011] and 2.9 [P = 0.032], respectively). The estimated time from seroconversion to AIDS and AIDS-related death was 5.0 and 8.0 years for A3/02, 6.2 and 9.0 years for CRF02_AG, and 7.2 and 11.3 years for A3. CONCLUSION: Our results show that there are differences in disease progression between HIV-1 A-like subtypes/CRFs. Individuals infected with A3/02 have among the fastest progression rates to AIDS reported to date. Determining the HIV-1 subtype of infected individuals could be important in the management of HIV-1 infections.
BACKGROUND:Human immunodeficiency virus type 1 (HIV-1) is divided into subtypes and circulating recombinant forms (CRFs) but the impact of subtype/CRF on disease progression is not fully understood. METHODS: We determined the HIV-1 subtype/CRF of 152 seroincident individuals from Guinea-Bissau, based on the C2-V3 region of env. Disease progression was measured as time from estimated seroconversion to AIDS and AIDS-related death. Hazard ratios (HRs) were calculated using a Cox proportional hazard model, adjusting for gender and age at seroconversion. RESULTS: The major subtypes/CRFs identified were CRF02_AG (53%), A3 (29%), and A3/02 (a recombinant of A3 and CRF02_AG) (13%). Infection with A3/02 was associated with a close to 3-fold increased risk of AIDS and AIDS-related death compared to A3 (HR = 2.6 [P = 0.011] and 2.9 [P = 0.032], respectively). The estimated time from seroconversion to AIDS and AIDS-related death was 5.0 and 8.0 years for A3/02, 6.2 and 9.0 years for CRF02_AG, and 7.2 and 11.3 years for A3. CONCLUSION: Our results show that there are differences in disease progression between HIV-1 A-like subtypes/CRFs. Individuals infected with A3/02 have among the fastest progression rates to AIDS reported to date. Determining the HIV-1 subtype of infected individuals could be important in the management of HIV-1 infections.
Entities:
Keywords:
CRF; HIV-1; West Africa; disease progression; subtype
Authors: Marion W Kiguoya; Jaclyn K Mann; Denis Chopera; Kamini Gounder; Guinevere Q Lee; Peter W Hunt; Jeffrey N Martin; T Blake Ball; Joshua Kimani; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u Journal: J Virol Date: 2017-06-09 Impact factor: 5.103
Authors: Lisa Naidoo; Zinhle Mzobe; Steven W Jin; Erasha Rajkoomar; Tarylee Reddy; Mark A Brockman; Zabrina L Brumme; Thumbi Ndung'u; Jaclyn K Mann Journal: Virology Date: 2019-02-21 Impact factor: 3.616
Authors: Marie Borggren; Sanne Skov Jensen; Leo Heyndrickx; Angelica A Palm; Jan Gerstoft; Gitte Kronborg; Bo Langhoff Hønge; Sanne Jespersen; Zacarias José da Silva; Ingrid Karlsson; Anders Fomsgaard Journal: AIDS Res Hum Retroviruses Date: 2016-01-07 Impact factor: 2.205
Authors: Isabel Inês M de Pina-Araujo; Monick L Guimarães; Gonzalo Bello; Ana Carolina P Vicente; Mariza G Morgado Journal: PLoS One Date: 2014-04-24 Impact factor: 3.240
Authors: Joakim Esbjörnsson; Mattias Mild; Anne Audelin; Jannik Fonager; Helena Skar; Louise Bruun Jørgensen; Kirsi Liitsola; Per Björkman; Göran Bratt; Magnus Gisslén; Anders Sönnerborg; Claus Nielsen; Patrik Medstrand; Jan Albert Journal: Virus Evol Date: 2016-04-27
Authors: Miguel A Garcia-Knight; Jennifer Slyker; Barbara Lohman Payne; Sergei L Kosakovsky Pond; Thushan I de Silva; Bhavna Chohan; Brian Khasimwa; Dorothy Mbori-Ngacha; Grace John-Stewart; Sarah L Rowland-Jones; Joakim Esbjörnsson Journal: Sci Rep Date: 2016-07-12 Impact factor: 4.379
Authors: Chih-Hao Chang; Nicolaas C Kist; Tammy L Stuart Chester; Vattipally B Sreenu; Melissa Herman; Ma Luo; Daniel Lunn; John Bell; Francis A Plummer; T Blake Ball; Aris Katzourakis; Astrid K N Iversen Journal: Sci Rep Date: 2015-06-17 Impact factor: 4.379